Mark MACIELAG,Raymond J. PATCH,Rui ZHANG,Martin A. CASE,Shamina M. RANGWALA,James N. LEONARD,Raul C. CAMACHO,Michael J. HUNTER,Katharine E. D'AQUINO,Wilson EDWARDS,Ronald V. SWANSON,Wenying JIAN,Yue-M
申请号：
US16542751
公开号：
US20190367577A1
申请日:
2019.08.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to a monoclonal antibody platform designed to be coupled to therapeutic peptides to increase the half-life of the therapeutic peptide in a subject. The invention also relates to pharmaceutical compositions and methods for use thereof.
